INFLUENCE OF DOSE AND DURATION OF INFUSION OF INTERLEUKIN-2 ON TOXICITY AND IMMUNOMODULATION

被引：145

作者：

THOMPSON, JA ^{[1
]}

LEE, DJ ^{[1
]}

LINDGREN, CG ^{[1
]}

BENZ, LA ^{[1
]}

COLLINS, C ^{[1
]}

LEVITT, D ^{[1
]}

FEFER, A ^{[1
]}

机构：

[1] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 04期

关键词：

D O I：

10.1200/JCO.1988.6.4.669

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：669 / 678

页数：10

共 36 条

[1] PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].

ATKINS, MB ;

GOULD, JA ;

ALLEGRETTA, M ;

LI, JJ ;

DEMPSEY, RA ;

RUDDERS, RA ;

PARKINSON, DR ;

REICHLIN, S ;

MIER, JW .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391

[2] POTENTIAL USES OF INTERLEUKIN-2 IN CANCER-THERAPY [J].

CHEEVER, MA ;

THOMPSON, JA ;

PEACE, DJ ;

GREENBERG, PD .

IMMUNOBIOLOGY, 1986, 172 (3-5) :365-382

[3]

CHEEVER MA, 1985, J IMMUNOL, V134, P3895

[4]

CONTA BS, 1985, J IMMUNOL, V134, P2185

[5]

DAMLE NK, 1986, J IMMUNOL, V137, P2814

[6]

ETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784

[7]

GOODMAN, PHARM BASIS THERAPEU, P696

[8]

HONDA K, 1983, J IMMUNOL, V130, P988

[9]

LOTZE MT, 1987, CANCER RES, V47, P2188

[10]

LOTZE MT, 1985, J IMMUNOL, V134, P157

← 1 2 3 4 →